On Monday, Oct. 8, my First Year Seminar, Writing with Pictures: An Introduction to Writing Picture Books and Graphic Novels, ...

From transformative weight loss treatment to a potential blockbuster for Alzheimer's, Dave Ricks of Eli Lilly is having a ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 519.47% and ...

Monday’s edition of Forbes Daily covers fresh records for S&P 500 and bitcoin, gambling in the UAE, Musk surpasses $300B, open questions for H-1B visa holders and more.

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.

Viking Therapeutics released new data on an obesity pill that may eventually compete with blockbuster shots from Eli Lilly and Novo Nordisk, stoking further takeout speculation for the company.

But earnings in the new range would still wind up being more than twice what the company registered for 2023. Shares of Indianapolis-based Eli Lilly and Co. were down 6%, or $57.02, to $846.56 in ...

Please go ahead. Thank you, Paul, and good morning, everybody. Thanks for joining us for Eli Lilly and company's Q3 2024 earnings call. I'm Joe Fletcher, Senior Vice President of Investor Relations.

Please go ahead. Thank you, Paul, and good morning, everybody. Thanks for joining us for Eli Lilly and Company's Q3 2024 earnings call. I'm Joe Fletcher, Senior Vice President of Investor Relations.

Eli Lilly and Company reported third quarter results and ... And we see a similar picture for adjusted earnings per share. Instead of a previous guidance of $16.10 to $16.60 for non-GAAP earnings ...